{"doi":"10.1101/2025.01.05.25320011","title":"First Measurement: Proactive Immune Cell Sparing in Radiation Therapy","abstract":"Abstract Purpose Radiation Therapy (RT) can modulate the immune system and generate anti-tumor T cells. However, this anti-tumor-activity is countered by radiation-induced immunosuppression (RIIS). Clinical advantages of proactively sparing RT dose to immune rich organs have not previously been evaluated. Methods We conducted a phase II randomized trial from 2020 to 2023, enrolling 51 early-stage lung cancer patients treated with SBRT, to evaluate the effect of dose reduction to immune rich organs on RIIS. Two groups were: RIIS-optimized-treatment (lowering the dose to blood, bone-marrow and lymph-node-stations) and standard-treatment. All treatments followed national protocol guidelines. Peripheral blood was collected at baseline, immediately, 4-weeks and 6-months post-treatment. Results ALC changes from baseline immediately, 4-weeks and 6-months post-SBRT are: optimized-arm: -16%, -22%, -16%, standard-arm: -31%, -34%, -26%, leading to an overall-all-time-point improvement in ALC reduction in the optimized-arm compared to the standard-arm of 13.4 (5.3) % (95% CI, 2.8 to 24.0; p = 0.01). Central tumors had the largest improvement in ALC from baseline: optimized-arm: - 8%, -18%, -14%, standard-arm: -39%, -43%, -47%, leading to an overall-all-time-point improvement in ALC reduction in the optimized-arm compared to the standard-arm of 29.5 (9.6) % (95% CI, 10.1 to 48.9; p = 0.004). Grade 3 lymphopenia occurred in 15.4% of standard arm patients but was absent in the optimized arm. Additionally, 2.8 times more patients in the optimized arm experienced an ALC increase post-SBRT. Dose to organs such as the heart, great vessels, thoracic spine, and lymph nodes significantly correlated with RIIS. A trend towards increased Event-Free-Survival (two-year: 75.0% (SE = 10.8%) versus 59.8% (SE = 11.2%), p =0·10) and Overall Survival (two-year: 93.4% (SE=6.1%) versus 69.4% (SE=10.5%), p =0·14) was observed with optimized-planning compared to standard-planning in treatment naïve patients. Conclusion Reducing RT dose to immune rich organs significantly reduces RIIS compared to standard-of-care. This has implications in enhancing immune system mediated anti-tumor-activity. (Funded by National Cancer Institute and others. ClinicalTrials.gov number, NCT04273893 )","journal":"medRxiv","year":2025,"id":560009,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9605,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT04273893"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1280856,"name":"Cam Nguyen","orcid":null,"position":1,"is_corresponding":false},{"id":299095,"name":"Mark R. Conaway","orcid":"0000-0002-0459-2336","position":2,"is_corresponding":false},{"id":1280860,"name":"Paul W. Read","orcid":null,"position":3,"is_corresponding":false},{"id":1280858,"name":"Kara D. Romano","orcid":null,"position":4,"is_corresponding":false},{"id":560985,"name":"Lawrence G. Lum","orcid":"0000-0001-7561-6035","position":5,"is_corresponding":false},{"id":560986,"name":"Archana Thakur","orcid":"0000-0003-3876-9555","position":6,"is_corresponding":false},{"id":1462182,"name":"D. Lain","orcid":null,"position":7,"is_corresponding":false},{"id":1462183,"name":"C. McLaughlin","orcid":null,"position":8,"is_corresponding":false},{"id":1462184,"name":"Christopher K Luminais","orcid":null,"position":9,"is_corresponding":false},{"id":1462185,"name":"Song Wood","orcid":null,"position":10,"is_corresponding":false},{"id":336513,"name":"Grant R. Williams","orcid":"0000-0003-4294-5232","position":11,"is_corresponding":false},{"id":712819,"name":"Joe Chen","orcid":"0000-0002-4906-6110","position":12,"is_corresponding":false},{"id":1462186,"name":"Bryant Walker","orcid":null,"position":13,"is_corresponding":false},{"id":905631,"name":"Damon Sprouts","orcid":null,"position":14,"is_corresponding":false},{"id":1461683,"name":"Donald A. Muller","orcid":"0000-0002-2393-6528","position":15,"is_corresponding":false},{"id":1300246,"name":"Kristin Ward","orcid":"0000-0002-7310-288X","position":16,"is_corresponding":false},{"id":1462187,"name":"Sunil Dutta","orcid":null,"position":17,"is_corresponding":false},{"id":1462188,"name":"Jason C. Sanders","orcid":null,"position":18,"is_corresponding":false},{"id":1461684,"name":"David Cousins","orcid":"0000-0003-1234-2983","position":19,"is_corresponding":false},{"id":1461685,"name":"Ebenezer Aquisman Asare","orcid":"0000-0003-1185-1479","position":20,"is_corresponding":false},{"id":1462189,"name":"Emily Nesbit","orcid":null,"position":21,"is_corresponding":false},{"id":1462190,"name":"Y. Chavis","orcid":null,"position":22,"is_corresponding":false},{"id":1462191,"name":"Kristin Walker","orcid":null,"position":23,"is_corresponding":false},{"id":414722,"name":"Einsley Janowski","orcid":null,"position":24,"is_corresponding":false},{"id":356565,"name":"Timothy N. Showalter","orcid":"0000-0003-1373-8496","position":25,"is_corresponding":false},{"id":307651,"name":"James M. Larner","orcid":"0000-0002-8679-7772","position":26,"is_corresponding":false},{"id":1106576,"name":"K. Wijesooriya","orcid":"0000-0002-4283-1609","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":null,"created_at":"2026-07-19T02:55:39.010633Z","pmid":"39830271","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}